Effects of alpha-mangostin encapsulated in nanostructured lipid carriers in mice with cerebral ischemia reperfusion injury

Cerebral ischemia reperfusion injury (CIRI) is a phenomenon in which the cerebral blood supply is restored after a period of ischemia, resulting in irreversible damage to brain tissue. Oxidative stress plays a crucial role in the development of CIRI, therefore, targeting oxidative stress might be an...

Full description

Bibliographic Details
Main Authors: Romgase Sakamula, Wachiryah Thong-asa, Teerapong Yata
Format: Article
Language:English
Published: Penerbit Universiti Kebangsaan Malaysia 2021
Online Access:http://journalarticle.ukm.my/17561/
http://journalarticle.ukm.my/17561/1/15.pdf
_version_ 1848814344115060736
author Romgase Sakamula,
Wachiryah Thong-asa,
Teerapong Yata,
author_facet Romgase Sakamula,
Wachiryah Thong-asa,
Teerapong Yata,
author_sort Romgase Sakamula,
building UKM Institutional Repository
collection Online Access
description Cerebral ischemia reperfusion injury (CIRI) is a phenomenon in which the cerebral blood supply is restored after a period of ischemia, resulting in irreversible damage to brain tissue. Oxidative stress plays a crucial role in the development of CIRI, therefore, targeting oxidative stress might be an effective strategy for CIRI prevention and treatment. Many therapeutic substances possess antioxidant and protective properties against neurodegenerative disorders but lack of in vivo application due to their solubility, and bioavailability. We investigated the effects of alpha-mangostin (αM) encapsulated in nanostructured lipid carriers (αM-NLC) on CIRI in mice. Forty male ICR mice were randomly divided into four groups: Sham, ischemia reperfusion (IR), ischemia reperfusion with 25 mg/kg of αM (IR+αM), and ischemia reperfusion with 25 mg/kg of αM-NLC (IR+αM-NLC). After 6 days of oral administrations, IR was delivered using 30 min of bilateral common carotid artery occlusion, followed by 45 min of reperfusion. Cerebral infarction volume, hippocampal neuronal and corpus callosum (CC) white matter damage, malondialdehyde (MDA) level, and catalase (CAT) activity were evaluated. Our results indicated that αM and αM-NLC prevent lipid peroxidation as well as hippocampal CA1, CA3, and CC damage (p<0.05). Only αM-NLC prevented cerebral infarction and enhanced CAT activity (p<0.05). We therefore conclude that αM and αM-NLC have neuroprotective effects against CIRI, and NLC increases therapeutic efficacy of αM against CIRI.
first_indexed 2025-11-15T00:32:35Z
format Article
id oai:generic.eprints.org:17561
institution Universiti Kebangasaan Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T00:32:35Z
publishDate 2021
publisher Penerbit Universiti Kebangsaan Malaysia
recordtype eprints
repository_type Digital Repository
spelling oai:generic.eprints.org:175612021-11-15T03:33:36Z http://journalarticle.ukm.my/17561/ Effects of alpha-mangostin encapsulated in nanostructured lipid carriers in mice with cerebral ischemia reperfusion injury Romgase Sakamula, Wachiryah Thong-asa, Teerapong Yata, Cerebral ischemia reperfusion injury (CIRI) is a phenomenon in which the cerebral blood supply is restored after a period of ischemia, resulting in irreversible damage to brain tissue. Oxidative stress plays a crucial role in the development of CIRI, therefore, targeting oxidative stress might be an effective strategy for CIRI prevention and treatment. Many therapeutic substances possess antioxidant and protective properties against neurodegenerative disorders but lack of in vivo application due to their solubility, and bioavailability. We investigated the effects of alpha-mangostin (αM) encapsulated in nanostructured lipid carriers (αM-NLC) on CIRI in mice. Forty male ICR mice were randomly divided into four groups: Sham, ischemia reperfusion (IR), ischemia reperfusion with 25 mg/kg of αM (IR+αM), and ischemia reperfusion with 25 mg/kg of αM-NLC (IR+αM-NLC). After 6 days of oral administrations, IR was delivered using 30 min of bilateral common carotid artery occlusion, followed by 45 min of reperfusion. Cerebral infarction volume, hippocampal neuronal and corpus callosum (CC) white matter damage, malondialdehyde (MDA) level, and catalase (CAT) activity were evaluated. Our results indicated that αM and αM-NLC prevent lipid peroxidation as well as hippocampal CA1, CA3, and CC damage (p<0.05). Only αM-NLC prevented cerebral infarction and enhanced CAT activity (p<0.05). We therefore conclude that αM and αM-NLC have neuroprotective effects against CIRI, and NLC increases therapeutic efficacy of αM against CIRI. Penerbit Universiti Kebangsaan Malaysia 2021-07 Article PeerReviewed application/pdf en http://journalarticle.ukm.my/17561/1/15.pdf Romgase Sakamula, and Wachiryah Thong-asa, and Teerapong Yata, (2021) Effects of alpha-mangostin encapsulated in nanostructured lipid carriers in mice with cerebral ischemia reperfusion injury. Sains Malaysiana, 50 (7). pp. 2007-2015. ISSN 0126-6039 https://www.ukm.my/jsm/malay_journals/jilid50bil7_2021/KandunganJilid50Bil7_2021.html
spellingShingle Romgase Sakamula,
Wachiryah Thong-asa,
Teerapong Yata,
Effects of alpha-mangostin encapsulated in nanostructured lipid carriers in mice with cerebral ischemia reperfusion injury
title Effects of alpha-mangostin encapsulated in nanostructured lipid carriers in mice with cerebral ischemia reperfusion injury
title_full Effects of alpha-mangostin encapsulated in nanostructured lipid carriers in mice with cerebral ischemia reperfusion injury
title_fullStr Effects of alpha-mangostin encapsulated in nanostructured lipid carriers in mice with cerebral ischemia reperfusion injury
title_full_unstemmed Effects of alpha-mangostin encapsulated in nanostructured lipid carriers in mice with cerebral ischemia reperfusion injury
title_short Effects of alpha-mangostin encapsulated in nanostructured lipid carriers in mice with cerebral ischemia reperfusion injury
title_sort effects of alpha-mangostin encapsulated in nanostructured lipid carriers in mice with cerebral ischemia reperfusion injury
url http://journalarticle.ukm.my/17561/
http://journalarticle.ukm.my/17561/
http://journalarticle.ukm.my/17561/1/15.pdf